Yes the company is paying for this article to be created and widely distributed to the media.
The company appears to want to raise public awareness of Blarcamasine. But until a NDA is submitted to the FDA it maybe premature here in the US.
Maybe to help boost share price, however no sign of it today, although more likely in the next couple of weeks as potential investors do their due diligence.
To me this is a sign of confidence and money well spent.
Market Data 
Markets 
AI
